Skip to main content
OpenTrials

Clinical trial condition

Immune Thrombocytopenia

Explore clinical trials studying Immune Thrombocytopenia. Study availability and eligibility vary by location and protocol.

96 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Immune Thrombocytopenia trial results

Completed

Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer

NCT06444477

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +19 more
Locations
  • AP-HP Hôpital Jean Verdier service de médecine interne Bondy, France
  • CHU de Clermont-Ferrand - service de médecine interne Clermont-Ferrand, France
  • AP-HP Hôpital Mondor service de médecine interne Créteil, France
  • AP-HP Hôpital Bicêtre service de médecine interne Le Kremlin-Bicêtre, France
View all 20 locations
View Trial Details
Completed

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

NCT03939637

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Phoenix CHildren's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 27 locations
View Trial Details
Completed

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

NCT04943042

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Swedish Orphan Biovitrum Research Site 131 Zagreb, Croatia
  • Swedish Orphan Biovitrum Research Site 122 Brno, Czechia
  • Swedish Orphan Biovitrum Research Site 123 Ostrava, Czechia
  • Swedish Orphan Biovitrum Research Site 121 Prague, Czechia
View all 55 locations
View Trial Details
Completed

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

NCT02298075

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • S.O.C. di Medicina Interna B - Ospedale - Cardinal Massaia di Asti Asti, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" Bologna, Italy
  • Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi Catania, Italy
  • Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano Florence, Italy
View all 13 locations
View Trial Details
Completed

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Sobi Site 110 Tucson, Arizona, United States
  • Sobi Site 119 Whittier, California, United States
  • Sobi Site 123 Washington D.C., District of Columbia, United States
  • Sobi Site 129 Miami, Florida, United States
View all 20 locations
View Trial Details
Completed

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

NCT04056195

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California, 1441 Eastlake Ave. Los Angeles, California, United States
  • Duke University Medical Center, 2301 Erwin Road Durham, North Carolina, United States
  • East Carolina University, 600 Moye Boulevard Greenville, North Carolina, United States
  • The Cleveland Clinic Foundation, 9500 Euclid Avenue Cleveland, Ohio, United States
View all 27 locations
View Trial Details

Related conditions